+Search query
-Structure paper
Title | 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 65, Page 2926-2939, Year 2022 |
Publish date | Feb 1, 2021 (structure data deposition date) |
Authors | Konno, S. / Kobayashi, K. / Senda, M. / Funai, Y. / Seki, Y. / Tamai, I. / Schakel, L. / Sakata, K. / Pillaiyar, T. / Taguchi, A. ...Konno, S. / Kobayashi, K. / Senda, M. / Funai, Y. / Seki, Y. / Tamai, I. / Schakel, L. / Sakata, K. / Pillaiyar, T. / Taguchi, A. / Taniguchi, A. / Gutschow, M. / Muller, C.E. / Takeuchi, K. / Hirohama, M. / Kawaguchi, A. / Kojima, M. / Senda, T. / Shirasaka, Y. / Kamitani, W. / Hayashi, Y. |
External links | J. Med. Chem. / PubMed:34313428 |
Methods | X-ray diffraction |
Resolution | 1.65 - 2.15 Å |
Structure data | PDB-7e18: PDB-7e19: |
Chemicals | ChemComp-HUR: ChemComp-EDO: ChemComp-HOH: ChemComp-HUO: |
Source |
|
Keywords | HYDROLASE / SARS-CoV-2 3CL protease |